{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T23:23:43Z","timestamp":1778628223295,"version":"3.51.4"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024370","name":"Ministero dell'Istruzione dell'Universita e della Ricerca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024370","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002803","name":"Cariplo Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002803","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.nbd.2024.106413","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T11:21:21Z","timestamp":1705749681000},"page":"106413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease"],"prefix":"10.1016","volume":"192","author":[{"given":"Alberto","family":"Imarisio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isar","family":"Yahyavi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micol","family":"Avenali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Di Maio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriele","family":"Buongarzone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Galandra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Picascia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asia","family":"Filosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Gasparri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Monti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Rondanelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Pacchetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Errico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enza Maria","family":"Valente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Usiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2024.106413_bb0005","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.nucmedbio.2005.07.004","article-title":"Preferred stereoselective brain uptake of d-serine - a modulator of glutamatergic neurotransmission","volume":"32","author":"Bauer","year":"2005","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.nbd.2024.106413_bb0010","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.neurobiolaging.2016.03.017","article-title":"CSF d-serine concentrations are similar in Alzheimer\u2019s disease, other dementias, and elderly controls","volume":"42","author":"Biemans","year":"2016","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106413_bb0015","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1016\/S0140-6736(21)00218-X","article-title":"Parkinson\u2019s disease","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.nbd.2024.106413_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2022.105697","article-title":"Striatal glutamatergic hyperactivity in Parkinson\u2019s disease","volume":"168","author":"Campanelli","year":"2022","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2024.106413_bb0025","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/cdd.2016.158","article-title":"DATF4 regulation of mitochondrial folate-mediated one-carbon metabolism is neuroprotective","volume":"24","author":"Celardo","year":"2017","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.nbd.2024.106413_bb0030","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3233\/JPD-191683","article-title":"Parkinson\u2019s disease in women and men: What\u2019s the difference?","volume":"9","author":"Cerri","year":"2019","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.nbd.2024.106413_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9123840","article-title":"Cerebrospinal fluid and serum d-serine levels in patients with alzheimer\u2019s disease: a systematic review and meta-analysis","volume":"9","author":"Chang","year":"2020","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.nbd.2024.106413_bb0040","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s13148-019-0732-z","article-title":"Selective demethylation of two CpG sites causes postnatal activation of the Dao gene and consequent removal of D-serine within the mouse cerebellum","volume":"11","author":"Cuomo","year":"2019","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.nbd.2024.106413_bb0045","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.molmed.2023.09.001","article-title":"d-amino acids: new clinical pathways for brain diseases","volume":"29","author":"de Souza","year":"2023","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.nbd.2024.106413_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106203","article-title":"Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson\u2019s disease patients","volume":"184","author":"Di Maio","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2024.106413_bb0055","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0006-3223(99)00133-X","article-title":"IV glycine and oral d-cycloserine effects on plasma and CSF amino acids in healthy humans","volume":"47","author":"D\u2019Souza","year":"2000","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106413_bb0060","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1002\/mds.21507","article-title":"Clinical diagnostic criteria for dementia associated with Parkinson\u2019s disease","volume":"22","author":"Emre","year":"2007","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106413_bb0065","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191670","article-title":"Serum amino acid profile in patients with Parkinson\u2019s disease","volume":"13","author":"Figura","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2024.106413_bb0070","series-title":"Molecular Mechanisms of l-DOPA-Induced Dyskinesia","first-page":"95","author":"Fisone","year":"2011"},{"key":"10.1016\/j.nbd.2024.106413_bb0075","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174452","article-title":"Effect of the glycine transporter 1 inhibitor ALX-5407 on dyskinesia, psychosis-like behaviours and parkinsonism in the MPTP-lesioned marmoset","volume":"910","author":"Frouni","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2024.106413_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175090","article-title":"Effect of glycine transporter 1 inhibition with bitopertin on parkinsonism and L-DOPA induced dyskinesia in the 6-OHDA-lesioned rat","volume":"929","author":"Frouni","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2024.106413_bb0085","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1017\/S1461145711001015","article-title":"D-serine adjuvant treatment alleviates behavioural and motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Gelfin","year":"2012","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.nbd.2024.106413_bb0090","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s00726-017-2459-5","article-title":"An overview on d - amino acids","volume":"49","author":"Genchi","year":"2017","journal-title":"Amino Acids"},{"key":"10.1016\/j.nbd.2024.106413_bb0095","series-title":"Mammals Sustain Amino Acid Homochirality against Chiral Conversion by Symbiotic Microbes 1\u20139","author":"Gonda","year":"2023"},{"key":"10.1016\/j.nbd.2024.106413_bb0100","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1471-4159.1984.tb02756.x","article-title":"Amino acids in plasma and CSF and monoamine metabolites in CSF: interrelationship in healthy subjects","volume":"42","author":"Hagenfeldt","year":"1984","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2024.106413_bb0105","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev-nutr-061021-022648","article-title":"Sources and sinks of serine in nutrition, health, and disease","volume":"43","author":"Handzlik","year":"2023","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.nbd.2024.106413_bb0110","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ejphar.2004.05.036","article-title":"Effect of systemic administration of D-serine on the levels of D- and L-serine in several brain areas and periphery of rat","volume":"495","author":"Hashimoto","year":"2004","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.nbd.2024.106413_bb0115","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/j.pnpbp.2005.04.023","article-title":"Reduced D-serine to total serine ratio in the cerebrospinal fluid of drug naive schizophrenic patients","volume":"29","author":"Hashimoto","year":"2005","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106413_bb0120","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/mds.27802","article-title":"Update of the MDS research criteria for prodromal Parkinson\u2019s disease","volume":"34","author":"Heinzel","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106413_bb0125","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/mds.25306","article-title":"Glycine site agonists of the N-methyl-d-aspartate receptor and Parkinson\u2019s disease: a hypothesis","volume":"28","author":"Heresco-Levy","year":"2013","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106413_bb0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-41608-0","article-title":"D -serine reflects kidney function and diseases","volume":"9","author":"Hesaka","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2024.106413_bb0140","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.bbr.2011.01.028","article-title":"Effects of d-cycloserine on MPTP-induced behavioral and neurological changes: potential for treatment of Parkinson\u2019s disease dementia","volume":"219","author":"Ho","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.nbd.2024.106413_bb0145","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2024.106413_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091987","article-title":"Serine metabolism in health and disease and as a conditionally essential amino acid","volume":"14","author":"Hole\u010dek","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.nbd.2024.106413_bb0155","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.neuint.2011.08.017","article-title":"Levels of d-serine in the brain and peripheral organs of serine racemase (Srr) knock-out mice","volume":"59","author":"Horio","year":"2011","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2024.106413_bb0160","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000526376","article-title":"Synaptic neurofilaments and GluN1-neurofilament light chain interaction in experimental models of \u03b1-synucleinopathies","volume":"22","author":"Imarisio","year":"2022","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.nbd.2024.106413_bb0165","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.3390\/biomedicines10071550","article-title":"NMDA and AMPA receptors at synapses: novel targets for tau and \u03b1-synuclein proteinopathies","volume":"10","author":"Italia","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.nbd.2024.106413_bb0170","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/ageing\/26.5.353","article-title":"The Parkinson\u2019s disease questionnaire (PDQ-39): development and validation of a Parkinson\u2019s disease summary index score","volume":"26","author":"Jenkinson","year":"1997","journal-title":"Age Ageing"},{"key":"10.1016\/j.nbd.2024.106413_bb0175","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1111\/ene.14470","article-title":"Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson\u2019s disease: review and meta-analysis","volume":"27","author":"Jim\u00e9nez-Jim\u00e9nez","year":"2020","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.nbd.2024.106413_bb0180","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1002\/mds.29410","article-title":"Levodopa dose equivalency in Parkinson\u2019s disease: updated systematic review and proposals","volume":"38","author":"Jost","year":"2023","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106413_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101223","article-title":"Measurement of glomerular filtration rate using endogenous D-serine clearance in living kidney transplant donors and recipients","volume":"43","author":"Kawamura","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.nbd.2024.106413_bb0190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep26137","article-title":"Chiral amino acid metabolomics for novel biomarker screening in the prognosis of chronic kidney disease","volume":"6","author":"Kimura","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2024.106413_bb0195","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1021\/acschemneuro.8b00383","article-title":"Alpha-synuclein in peripheral tissues in Parkinson\u2019s disease","volume":"10","author":"Ma","year":"2019","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2024.106413_bb0200","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.52","article-title":"d-serine levels in Alzheimer\u2019s disease: implications for novel biomarker development","volume":"5","author":"Madeira","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106413_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111271","article-title":"Insulin and serine metabolism as sex-specific hallmarks of Alzheimer\u2019s disease in the human hippocampus","volume":"40","author":"Maffioli","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2024.106413_bb0210","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.tibs.2020.11.007","article-title":"Mitochondrial dysfunction and mitophagy in Parkinson\u2019s disease: from mechanism to therapy","volume":"46","author":"Malpartida","year":"2021","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.nbd.2024.106413_bb0215","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11011-020-00623-1","article-title":"Linking chronic kidney disease and Parkinson\u2019s disease: a literature review","volume":"36","author":"Mel\u00e9ndez-Flores","year":"2021","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.nbd.2024.106413_bb0220","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.3390\/ijms22084231","article-title":"Biochemical and biophysical characterization of recombinant human 3-phosphoglycerate dehydrogenase","volume":"22","author":"Murtas","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.nbd.2024.106413_bb0225","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-45419-1","article-title":"The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson\u2019s disease patients","volume":"9","author":"Nuzzo","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2024.106413_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbapap.2020.140537","article-title":"Cerebrospinal fluid and serum d-serine concentrations are unaltered across the whole clinical spectrum of Alzheimer\u2019s disease","volume":"1868","author":"Nuzzo","year":"2020","journal-title":"Biochim. Biophys. Acta, Proteins Proteomics"},{"key":"10.1016\/j.nbd.2024.106413_bb0235","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1152\/ajplegacy.1971.221.6.1629","article-title":"Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection","volume":"221","author":"Oldendorf","year":"1971","journal-title":"Am. J. Physiol. Content"},{"key":"10.1016\/j.nbd.2024.106413_bb0240","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.neurobiolaging.2019.10.015","article-title":"Anti-GluA3 antibodies in frontotemporal dementia: effects on glutamatergic neurotransmission and synaptic failure","volume":"86","author":"Palese","year":"2020","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.nbd.2024.106413_bb0245","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.neuint.2012.03.008","article-title":"D-serine diffusion through the blood-brain barrier: effect on D-serine compartmentalization and storage","volume":"60","author":"Pernot","year":"2012","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.nbd.2024.106413_bb0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41398-021-01202-3","article-title":"Serum d-serine levels are altered in early phases of Alzheimer\u2019s disease: towards a precocious biomarker","volume":"11","author":"Piubelli","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.nbd.2024.106413_bb0255","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson\u2019s disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.nbd.2024.106413_bb0260","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2023.109344","article-title":"Sex steroid hormones, the estrous cycle, and rapid modulation of glutamatergic synapse properties in the striatal brain regions with a focus on 17\u03b2-estradiol and the nucleus accumbens","volume":"201","author":"Proa\u00f1o","year":"2024","journal-title":"Steroids"},{"key":"10.1016\/j.nbd.2024.106413_bb0265","doi-asserted-by":"crossref","first-page":"5363","DOI":"10.1007\/s00253-014-5726-3","article-title":"Bacterial synthesis of D-amino acids","volume":"98","author":"Radkov","year":"2014","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.nbd.2024.106413_bb0270","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1038\/sj.emboj.7601840","article-title":"D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis","volume":"26","author":"Sasabe","year":"2007","journal-title":"EMBO J."},{"key":"10.1016\/j.nbd.2024.106413_bb0275","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1073\/pnas.1114639109","article-title":"D-amino acid oxidase controls motoneuron degeneration through D-serine","volume":"109","author":"Sasabe","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2024.106413_bb0280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0086504","article-title":"Ischemic acute kidney injury perturbs homeostasis of serine enantiomers in the body fluid in mice: early detection of renal dysfunction using the ratio of serine enantiomers","volume":"9","author":"Sasabe","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2024.106413_bb0285","doi-asserted-by":"crossref","first-page":"16778","DOI":"10.1523\/JNEUROSCI.3041-12.2013","article-title":"Glycine transporter-1 inhibition promotes striatal axon sprouting via NMDA receptors in dopamine neurons","volume":"33","author":"Schmitz","year":"2013","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2024.106413_bb0290","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0006-8993(00)02036-9","article-title":"Effects of the partial glycine agonist d-cycloserine on cognitive functioning in chronic low dose MPTP-treated monkeys","volume":"860","author":"Schneider","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2024.106413_bb0295","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106226","article-title":"Perturbation of serine enantiomers homeostasis in the striatum of MPTP-lesioned monkeys and mice reflects the extent of dopaminergic midbrain degeneration","volume":"184","author":"Serra","year":"2023","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2024.106413_bb0300","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.brainres.2004.01.022","article-title":"Glycine and d-cycloserine attenuate vacuous chewing movements in a rat model of tardive dyskinesia","volume":"1004","author":"Shoham","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2024.106413_bb0305","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/j.1471-4159.1987.tb01039.x","article-title":"Kinetics of neutral amino acid transport across the blood-brain barrier","volume":"49","author":"Smith","year":"1987","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2024.106413_bb0310","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s12640-016-9612-x","article-title":"L-DOPA reverses the increased free amino acids tissue levels induced by dopamine depletion and rises GABA and tyrosine in the striatum","volume":"30","author":"Sol\u00eds","year":"2016","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.nbd.2024.106413_bb0315","series-title":"Serum d -Serine Accumulation after Proximal Renal Tubular Damage Involves Neutral Amino Acid Transporter Asc-1","first-page":"1","author":"Suzuki","year":"2019"},{"key":"10.1016\/j.nbd.2024.106413_bb0320","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00726-022-03140-w","article-title":"Chiral resolution of plasma amino acids reveals enantiomer-selective associations with organ functions","volume":"54","author":"Suzuki","year":"2022","journal-title":"Amino Acids"},{"key":"10.1016\/j.nbd.2024.106413_bb0325","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1046\/j.1471-4159.1997.69031286.x","article-title":"In vivo evidence for the link between L- and D-serine metabolism in rat cerebral cortex","volume":"69","author":"Takahashi","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.nbd.2024.106413_bb0330","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1146\/annurev.nutr.012809.104810","article-title":"Compartmentalization of mammalian folate-mediated one-carbon metabolism","volume":"30","author":"Tibbetts","year":"2010","journal-title":"Annu. Rev. Nutr."},{"key":"10.1016\/j.nbd.2024.106413_bb0335","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.tins.2016.09.007","article-title":"The rise and fall of the d -serine-mediated gliotransmission hypothesis","volume":"39","author":"Wolosker","year":"2016","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2024.106413_bb0340","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2014.08.052","article-title":"Changes in plasma d-serine, l-serine, and glycine levels in treatment-resistant schizophrenia before and after clozapine treatment","volume":"582","author":"Yamamori","year":"2014","journal-title":"Neurosci. Lett."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124000123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996124000123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:39:26Z","timestamp":1760852366000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996124000123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":67,"alternative-id":["S0969996124000123"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106413","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood D-serine levels correlate with aging and dopaminergic treatment in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2024.106413","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106413"}}